Clovis Oncology Inc(CLVS) is a stock of interest due to it’s movements. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about CLVS. We will be studying the movemnt so you can make the best descision as an investor.
First, we should get to know the company in discussion today. Here is a little about them:
Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer; and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.
The stock has moved upwards today by 37.78%. The high for today is 8.44 and today’s low is 6.36. This information is critical in deciding whether this investment is risky or safe. We can see since the stock is trending upwards which means that the volume of people selling this stock is greater than people who are buying it. Next we will be going over the forecast.
As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for Clovis Oncology Inc is 13.00 and the low forecast is 7.00. We can also get a look into the future by looking at past trends. Looking at Clovis Oncology Inc’s 5 year movement it seems it has fallen 62%.
If you found this article helpful please check out our others or signup for our newsletter below!